| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |